Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Bailey

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Pediatric Diabetes|May 2, 2021
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trialTadej Battelino, Ramin Tehranchi, Timothy Bailey, et al.
Diabetes Research and Clinical Practice|September 29, 2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapyAlice Y Y Cheng, Didac Mauricio, Robert Ritzel, et al.
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Molecular Cancer Therapeutics|August 31, 2012
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenograftsDavid E Gerber, Puja Gupta, Michael T Dellinger, et al.
Nucleic Acids Research|July 4, 2012
An in-depth map of polyadenylation sites in cancerYuefeng Lin, Zhihua Li, Fatih Ozsolak, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2015
Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoringGeorge Grunberger, Timothy Bailey, Pauline M Camacho, et al.
Biochemistry|August 16, 2006
Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapinJohn P Felix, Jessica Liu, William A Schmalhofer, et al.
JMIR Human Factors|June 11, 2024
Development of a Real-Time Dashboard for Overdose Touchpoints: User-Centered Design ApproachAmey Salvi, Logan A Gillenwater, Brandon P Cockrum, et al.
Pediatric Diabetes|June 25, 2011
Evaluation of a combined blood glucose monitoring and gaming system (Didget®) for motivation in children, adolescents, and young adults with type 1 diabetesGeorgeanna J Klingensmith, Javier Aisenberg, Francine Kaufman, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2013
A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsKevin C J Yuen, Gerard S Conway, Vera Popovic, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Pediatric Diabetes|May 2, 2021
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trialTadej Battelino, Ramin Tehranchi, Timothy Bailey, et al.
Diabetes Research and Clinical Practice|September 29, 2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapyAlice Y Y Cheng, Didac Mauricio, Robert Ritzel, et al.
Molecular Pharmacology|August 30, 2008
ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptorsWilliam A Schmalhofer, Jeffrey Calhoun, Rachel Burrows, et al.
Molecular Cancer Therapeutics|August 31, 2012
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenograftsDavid E Gerber, Puja Gupta, Michael T Dellinger, et al.
Nucleic Acids Research|July 4, 2012
An in-depth map of polyadenylation sites in cancerYuefeng Lin, Zhihua Li, Fatih Ozsolak, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 12, 2015
Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoringGeorge Grunberger, Timothy Bailey, Pauline M Camacho, et al.
Biochemistry|August 16, 2006
Characterization of Kir1.1 channels with the use of a radiolabeled derivative of tertiapinJohn P Felix, Jessica Liu, William A Schmalhofer, et al.
JMIR Human Factors|June 11, 2024
Development of a Real-Time Dashboard for Overdose Touchpoints: User-Centered Design ApproachAmey Salvi, Logan A Gillenwater, Brandon P Cockrum, et al.
Pediatric Diabetes|June 25, 2011
Evaluation of a combined blood glucose monitoring and gaming system (Didget®) for motivation in children, adolescents, and young adults with type 1 diabetesGeorgeanna J Klingensmith, Javier Aisenberg, Francine Kaufman, et al.
The Journal of Clinical Endocrinology and Metabolism|April 16, 2013
A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adultsKevin C J Yuen, Gerard S Conway, Vera Popovic, et al.
Pageof 6